Clarithromycin Export Market Intelligence: India's 334 Suppliers Shipping to 144 Countries — TransData Nexus 2026

Q: Who are the top clarithromycin exporters from India?

The top clarithromycin exporters from India are: 1. MICRO LABS LIMITED — $20.2M (20.5% market share); 2. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $15.8M (16.1% market share); 3. AUROBINDO PHARMA LTD — $7.8M (7.9% market share); 4. CAPLIN POINT LABORATORIES LIMITED — $5.8M (5.9% market share); 5. CIPLA LIMITED — $5.1M (5.1% market share). Together they account for 55.6% of India's total clarithromycin export value.

Q: What is the total export value of clarithromycin from India?

The total export value of clarithromycin from India is $98.4M USD, recorded across 3,576 shipment transactions from 334 active exporters to 144 destination countries. The average shipment value is $27.5K.

Q: Which countries import clarithromycin from India?

India exports clarithromycin to 144 countries worldwide. The top importing countries are: UNITED KINGDOM (18.6% share, $18.3M), BELGIUM (11.6% share, $11.4M), TANZANIA (8.5% share, $8.4M), UNITED STATES (8.5% share, $8.3M), KENYA (5.9% share, $5.8M). These five markets account for 53.1% of total export value.

Q: What is the average price of clarithromycin exports from India?

The average unit price for clarithromycin exports from India is $64.25 USD per unit, with prices ranging from $0.00 to $89112.90 depending on formulation, packaging, and order volume. The total market is valued at $98.4M across 3,576 shipments.

Q: Which ports handle clarithromycin exports from India?

The primary ports for clarithromycin exports from India are SAHAR AIR (10.2% of shipments), DELHI AIR CARGO ACC (INDEL4) (8.3% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.9% of shipments), DELHI AIR (7.2% of shipments), NHAVA SHEVA SEA (INNSA1) (6.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of clarithromycin?

India is one of the world's leading exporters of clarithromycin due to its large base of 334 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports clarithromycin to 144 countries, demonstrating 74% global market coverage.

Q: What certifications do Indian clarithromycin exporters need?

Indian clarithromycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import clarithromycin from India?

There are 811 registered buyers importing clarithromycin from India, spread across 144 countries. The repeat buyer rate is 58.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top clarithromycin supplier from India?

MICRO LABS LIMITED is the leading clarithromycin exporter from India with a market share of 20.5% and total export value of $20.2M across 308 shipments. The top 5 suppliers together control 55.6% of total export value.

Suresh Sormare

Clarithromycin

India Pharmaceutical Trade Intelligence

$98.4M334 Suppliers144 CountriesHS 30042063

ExportsIndia → UNITED KINGDOM18.6%India → BELGIUM11.6%

ImportsUNITED STATES → India$112.9K ROMANIA → India$7.6K

#1 Supplier: MICRO LABS #1 Buyer: BROWN AND

Clarithromycin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Clarithromycin to the World

Between 2022 and 2026, India exported $98.4M worth of clarithromycin across 3,576 verified shipments to 144 countries — covering 74% of world markets in the Antibiotics segment. The largest destination is UNITED KINGDOM (18.6%). MICRO LABS LIMITED leads with a 20.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30042063

Clarithromycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Clarithromycin export data snapshot — $98.4M · 334 exporters · 144 countriesTransData Nexus · Indian Customs Data

Top Clarithromycin Exporters from India

334 active exporters · Ranked by export value

View all 334 →

Top Clarithromycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MICRO LABS LIMITED	$20.2M	308	27	20.5%
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED

Top Countries Importing Clarithromycin from India

144 destination markets · Ranked by import value

All 144 countries →

Top Countries Importing Clarithromycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED KINGDOM	$18.3M	18.6%
2	BELGIUM	$11.4M	11.6%
3	TANZANIA	$8.4M	8.5%
4	UNITED STATES	$8.3M	8.5%
5	KENYA	$5.8M	5.9%
6	ECUADOR	$4.6M	4.7%
7	RUSSIA	$2.7M	2.7%
8	UGANDA	$2.3M	2.3%
9	FRANCE	$2.3M	2.3%
10	PHILIPPINES	$2.2M	2.2%

UNITED KINGDOM is India's largest clarithromycin export destination, absorbing 18.6% of total exports worth $18.3M. The top 5 importing countries — UNITED KINGDOM, BELGIUM, TANZANIA, UNITED STATES, KENYA — together account for 53.1% of India's total clarithromycin export value. The remaining 139 destination countries collectively receive the other 46.9%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Clarithromycin to India?

12 origin countries · Total import value: $138.0K

India imports clarithromycin from 12 countries with a combined import value of $138.0K. The largest supplier is UNITED STATES ($112.9K, 15 shipments), followed by ROMANIA and BRAZIL. All values are from Indian Customs (DGFT) import records.

Countries Supplying Clarithromycin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$112.9K	15	81.8%
2	ROMANIA	$7.6K	2	5.5%
3	BRAZIL	$5.9K	4	4.3%
4	NETHERLANDS	$2.3K	1	1.7%
5	IRELAND	$2.1K	2	1.5%
6	GERMANY	$1.6K	2	1.2%
7	AUSTRIA	$1.4K	1	1.0%
8	UNITED KINGDOM	$1.4K	7	1.0%
9	CHINA	$1.1K	5	0.8%
10	CANADA	$834	4	0.6%

Showing top 10 of 12 origin countries

UNITED STATES is the largest supplier of clarithromycin to India, accounting for 81.8% of total import value. The top 5 origin countries — UNITED STATES, ROMANIA, BRAZIL, NETHERLANDS, IRELAND — together supply 94.8% of India's clarithromycin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Clarithromycin — Export Intelligence Video

Visual overview of India's clarithromycin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's clarithromycin pharmaceutical import and export market — $98.4M in total trade, 334 verified manufacturers, and 144 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Clarithromycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Clarithromycin, a macrolide antibiotic, has been approved in the United States through multiple Abbreviated New Drug Applications (ANDAs). According to the FDA's Orange Book, numerous generic versions of clarithromycin have received approval, indicating a well-established presence in the U.S. market. The regulatory pathway for these approvals involves demonstrating bioequivalence to the reference listed drug, ensuring therapeutic equivalence.

Regarding import alerts, the FDA maintains a dynamic list to protect consumers from products that violate U.S. regulations. As of March 2026, there are no specific import alerts related to clarithromycin from Indian manufacturers. This absence suggests compliance with FDA standards among Indian exporters. Notably, India has 334 active exporters of clarithromycin, underscoring its significant role in supplying this antibiotic to the U.S. market.

2EU & UK Regulatory Framework

In the European Union, clarithromycin is subject to marketing authorization requirements overseen by the European Medicines Agency (EMA). Manufacturers must demonstrate compliance with EU Good Manufacturing Practice (GMP) standards to obtain and maintain these authorizations. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates the approval and monitoring of clarithromycin, ensuring adherence to UK-specific GMP requirements. The United Kingdom is a primary destination for Indian clarithromycin exports, accounting for 18.6% of the total export value, highlighting the importance of meeting these regulatory standards.

3WHO Essential Medicines & Global Standards

Clarithromycin is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025. This inclusion underscores its critical role in treating various bacterial infections globally. The WHO's International Pharmacopoeia provides standardized quality specifications for clarithromycin, ensuring consistency in its production and quality across different regions. These global standards facilitate the widespread acceptance and use of clarithromycin in diverse healthcare settings.

4India Regulatory Classification

In India, clarithromycin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including clarithromycin, to ensure affordability. As of March 2026, the ceiling price for clarithromycin has been set to balance accessibility with the economic viability for manufacturers. For export purposes, Indian manufacturers are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

The primary patents for clarithromycin have expired, leading to a robust generic market with multiple manufacturers producing the antibiotic. This competitive landscape has contributed to the widespread availability and affordability of clarithromycin globally.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines convened to update the Model List of Essential Medicines, reaffirming clarithromycin's inclusion due to its efficacy and safety profile. In September 2025, the WHO published the 24th edition of the Model List of Essential Medicines, which includes clarithromycin, highlighting its continued importance in global health. These developments reflect the ongoing recognition of clarithromycin's essential role in treating bacterial infections worldwide.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Clarithromycin

Retail & reference prices across 9 markets vs. India FOB export price of $64.25/unit

Global Price Benchmark for Clarithromycin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Data not available	USD	No specific government or regulatory references available.
United Kingdom	Data not available	GBP	No specific government or regulatory references available.
Germany	Data not available	EUR	No specific government or regulatory references available.
Australia	Data not available	AUD

Supply Chain Risk Assessment — Clarithromycin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of clarithromycin, heavily relies on imported Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs), with a significant portion sourced from China. This dependency exposes the supply chain to vulnerabilities stemming from geopolitical tensions and trade disruptions. For instance, in 2025, logistical constraints at major Chinese ports like Shanghai and Qingdao led to increased export prices for clarithromycin APIs, directly impacting global supply chains.

To mitigate such risks, the Indian government has initiated the Production Linked Incentive (PLI) scheme aimed at bolstering domestic API and KSM production. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules used in antibiotics, marking a significant step toward reducing import dependence.

2Supplier Concentration & Single-Source Risk

The export market for clarithromycin from India is notably concentrated, with the top five exporters—MICRO LABS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, AUROBINDO PHARMA LTD, CAPLIN POINT LABORATORIES LIMITED, and CIPLA LIMITED—accounting for 55.6% of total exports. MICRO LABS LIMITED alone holds a 20.5% share, indicating a significant reliance on a limited number of suppliers. Such concentration poses risks of supply disruptions if any of these key players face operational challenges.

Access Complete Clarithromycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,576 transactions across 144 markets.

Request Demo View Pricing

Frequently Asked Questions — Clarithromycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top clarithromycin exporters from India?

The leading clarithromycin exporters from India are MICRO LABS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, AUROBINDO PHARMA LTD, and 12 others. MICRO LABS LIMITED leads with 20.5% market share ($20.2M). The top 5 suppliers together control 55.6% of total export value.

What is the total export value of clarithromycin from India?

The total export value of clarithromycin from India is $98.4M, recorded across 3,576 shipments from 334 active exporters to 144 countries. The average shipment value is $27.5K.

Which countries import clarithromycin from India?

India exports clarithromycin to 144 countries. The top importing countries are UNITED KINGDOM (18.6%), BELGIUM (11.6%), TANZANIA (8.5%), UNITED STATES (8.5%), KENYA (5.9%), which together account for 53.1% of total export value.

What is the HS code for clarithromycin exports from India?

The primary HS code for clarithromycin exports from India is 30042063. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Clarithromycin

Clarithromycin

Top Clarithromycin Exporters from India

Top Countries Importing Clarithromycin from India

Who Supplies Clarithromycin to India?

Quick Facts

Related Antibiotics

Related Analysis

Need Details?

Clarithromycin — Export Intelligence Video

Regulatory Landscape — Clarithromycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Clarithromycin

Supply Chain Risk Assessment — Clarithromycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Clarithromycin Trade Intelligence

Frequently Asked Questions — Clarithromycin Exports from India

Who are the top clarithromycin exporters from India?

What is the total export value of clarithromycin from India?

Which countries import clarithromycin from India?

What is the HS code for clarithromycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of clarithromycin exports from India?

Which ports handle clarithromycin exports from India?

Why is India a leading exporter of clarithromycin?

What certifications do Indian clarithromycin exporters need?

How many buyers import clarithromycin from India?

What is the market share of the top clarithromycin exporter from India?

Analysis Methodology